Profile
LMDX DHR-PB TMO DHR IDXX A
Company Name LumiraDx Limited Danaher Corporation Thermo Fisher Scientific Inc. Danaher Corporation IDEXX Laboratories, Inc. Agilent Technologies, Inc.
Sector Healthcare Healthcare Healthcare Healthcare Healthcare Healthcare
Industry Medical - Diagnostics & Research Medical - Diagnostics & Research Medical - Diagnostics & Research Medical - Diagnostics & Research Medical - Diagnostics & Research Medical - Diagnostics & Research
Market Cap $5.10M $916.76B $159.89B $142.45B $39.41B $30.97B
Employees 1.21K 79.00K 125.00K 61.00K 11.00K 17.90K
CEO Ms. Veronique Ameye EMBA, Esq., M.B.A. Mr. Rainer M. Blair Mr. Marc N. Casper Mr. Rainer M. Blair Mr. Jonathan J. Mazelsky Mr. Padraig McDonnell
Ratings
LMDX DHR-PB TMO DHR IDXX A
Quant Rating Score 3 5 3 3 3 3
Quant Rating Neutral Strong Buy Neutral Neutral Neutral Neutral
Trading
LMDX DHR-PB TMO DHR IDXX A
Last Close $0.016 $1261.26 $403.13 $189.73 $491.7 $106.93
High 52 $0.02 $1261.26 $624.21 $280.76 $548.53 $154.64
Low 52 $0.02 $1261.26 $403.13 $174.64 $361.04 $99.29
Price vs. 52 Week High -20 % 0 % -35.42 % -32.42 % -10.36 % -30.85 %
Price vs. 52 Week Low -20 % 0 % 0 % 8.64 % 36.19 % 7.69 %
Total Return
LMDX DHR-PB TMO DHR IDXX A
1 Month Return 0 % 0 % -5.69 % 4.96 % 28.72 % 6.98 %
3 Month Return 0 % 0 % -27.08 % -6.77 % 5.76 % -25.58 %
6 Month Return 0 % 0 % -26.93 % -22.68 % 13.48 % -21.77 %
9 Month Return 0 % 0 % -32.38 % -29.23 % 1.83 % -21.89 %
YTD Return 0 % 0 % -22.51 % -17.35 % 18.93 % -20.4 %
1 Year Return 0 % 0 % -32.02 % -25.12 % -3.55 % -28.6 %
3 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
5 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
Dividends
LMDX DHR-PB TMO DHR IDXX A
Dividend Yield Percentage (TTM) - 0.58 % 0.38 % 0.57 % - 0.89 %
Dividend Paid and Capex Coverage Ration (TTM) -6.49 % 2.93 % 4.05 % 2.93 % 7.41 % 3.01 %
Dividend Per Share (TTM) - 1.13 % 1.6 % 1.13 % - 0.97 %
Payout Ratio (TTM) - 20.85 % 9.16 % 20.85 % - 21.92 %
Growth
LMDX DHR-PB TMO DHR IDXX A
Asset Growth -31.6 % 1.03 % 10.06 %
Gross Profit Growth -123.3 % 8.63 % 2.02 %
Revenue Growth -39.62 % 6.46 % -4.73 %
Revenue 3 Year 884.53 % 25.23 % 8 %
Revenue 5 Year 884.53 % 69.09 % 36.52 %
Revenue 10 Year 884.53 % 218.38 % 7.08 %
EBIT Growth -1631.69 % 3.47 % 3.77 %
Net Income Growth -345.79 % 5.07 % 3.95 %
Net Income 3 Yeari Growth Per Share -202.14 % 23.15 % 11.67 %
Net Income 5 Yeari Growth Per Share -202.14 % 116.76 % 30.32 %
Net Income 10 Yeari Growth Per Share -202.14 % 492.42 % 197.81 %
Operating Income Growth -1705.39 % 2.84 % 10.22 %
Operating Cash Flow Growth (CFG) -20.18 % 2.48 % -1.19 %
Operating 3 Year CFG -58.18 % 27.03 % 23.6 %
Operating 5 Year CFG -58.18 % 111.28 % 85.69 %
Operating 10 Year CFG -58.18 % 378.1 % 182 %
EPS Growth -156.45 % 5.9 % 5.21 %
EPS Diluted Growth -156.45 % 6.06 % 5.73 %
Book Value Per Share -137.38 % 8.24 % 2.3 %
Share Holder 3 Year Equity Growth Per Share 38.35 % 138.87 % 14.73 %
Share Holder 5 Year Equity Growth Per Share 38.35 % 838.67 % 34.5 %
Share Holder 10 Year Equity Growth Per Share 38.35 % 1547.69 % 27.76 %
Dividend Per Share Growth - - 4.82 %
Dividend 3 Year Growth Per Share - - 21.71 %
Dividend 5 Year Growth Per Share - - 44.02 %
Dividend 10 Year Growth Per Share - - 78.77 %
Debt Growth 19.37 % -7.53 % 23.95 %
Free Cash Flow Growth 22.44 % 3.26 % -6.85 %
Updated On 31 Dec 2022 31 Dec 2024 31 Oct 2024
Profitability
LMDX DHR-PB TMO DHR IDXX A
Gross Profit Margin TTM -13.87 % 59.74 % 41.74 % 59.74 % 61.32 % 53.97 %
Return on Assets TTM -101.86 % 4.76 % 6.58 % 4.76 % 27.85 % 10.57 %
Return on Equity TTM -1557.76 % 7.47 % 13.34 % 7.47 % 57.35 % 20.95 %
Return on Capital Employed TTM -92.05 % 6.66 % 8.53 % 6.66 % 55.24 % 14.73 %
Net Income Per EBT TTM 101.33 % 83.59 % 92.18 % 83.59 % 79.59 % 84.78 %
EBT Per Ebit TTM 137.9 % 93.35 % 96.45 % 93.35 % 97.98 % 100.34 %
EBIT Per Revenue TTM -126.32 % 20.26 % 17.08 % 20.26 % 29.19 % 22.65 %
Cash Flow To Debt Ratio TTM -40.4 % 37.92 % 23.81 % 37.92 % 91.41 % 50.46 %
Receivables Turnover TTM 3.9 6.79 5.07 6.79 6.51 4.92
Payables Turnover TTM 4.15 5.57 - 5.57 12.66 5.5
Inventory Turnover TTM 3.22 3.79 4.78 3.79 3.84 3.02
Fixed Asset Turnover TTM 195.77 % 466.14 % 459.74 % 466.14 % 471.66 % 359.75 %
Asset Turnover TTM 57.7 % 30.11 % 43.31 % 30.11 % 122.35 % 54.83 %
Operating Cash Flow Per Share TTM -0.57 8.72 21.53 8.72 11.74 5.95
Free Cash Flow Per Share TTM -0.66 6.84 17.79 6.84 10.16 4.6
Cash Per Share TTM 35.43 % 278.24 % 1573.28 % 278.24 % 198.83 % 514.74 %
Operating Cash Flow Sales Ratio TTM -63.7 % 26.23 % 18.97 % 26.23 % 24.63 % 25.98 %
Free Cash Flow Operating Cash Flow Ratio TTM 115.41 % 78.46 % 82.61 % 78.46 % 86.51 % 77.31 %
Cash Flow Coverage Ratios TTM -40.4 % 37.92 % 23.81 % 37.92 % 91.41 % 50.46 %
Price To Free Cash Flows Ratio TTM -0.03 28.44 23.78 29.06 47.04 23.61
Price To Operating Cash Flows Ratio TTM -0.03 22.34 19.67 22.82 41.73 18.24
Price Cash Flow Ratio TTM -0.03 22.34 19.67 22.82 41.73 18.24
Income Statement (TTM)
LMDX DHR-PB TMO DHR IDXX A
Revenue $0.25B $23.88B $42.88B $23.88B $3.9B $6.51B
Gross Profit $-0.04B $14.21B $17.7B $14.21B $2.38B $3.54B
Gross Profit Ratio -13.87% 59.5% 41.28% 59.5% 61.04% 54.3%
EBITDA $-0.27B $7.28B $11.8B $7.28B $1.28B $1.87B
Net Income $-0.45B $3.9B $6.34B $3.9B $0.89B $1.29B
EPS Diluted -1.59 5.29 16.53 5.29 10.67 4.43
Balance Sheet (MRQ)
LMDX DHR-PB TMO DHR IDXX A
Long Term Debt $0.38B $15.5B $29.06B $15.5B $0.55B $3.35B
Total Liabilities $0.55B $27.99B $47.65B $27.99B $1.7B $5.95B
Total Equity $-0.11B $49.55B $49.67B $49.55B $1.6B $5.9B
Total Investments $0.01B $0B $1.56B $0B $0.06B $0.18B
Total Debt $0.4B $16.01B $31.28B $16.01B $0.99B $3.39B
Total Assets $0.44B $77.54B $97.32B $77.54B $3.29B $11.85B
Cash Flow Statement (TTM)
LMDX DHR-PB TMO DHR IDXX A
Net Income $-0.45B $3.9B $6.34B $3.9B $0.89B $1.29B
Inventory $-0B $0.15B $0B $0.15B $-0.03B $0.03B
Dividends Paid $0B $-0.77B $-0.58B $-0.77B $0B $-0.27B
Operating Cash Flow $-0.16B $6.69B $8.67B $6.69B $0.93B $1.75B
Capital Expenditure $-0.02B $-1.39B $-1.4B $-1.39B $-0.13B $-0.38B
Related Stocks
Ticker Name Price
A Agilent Technologies, Inc. 106.93
ACRS Aclaris Therapeutics, Inc. 1.26
ADVB Advanced Biomed Inc. Common Stock 0.9489
AKU Akumin Inc. 0.2887
APDN Applied DNA Sciences, Inc. 0.821
AWH Aspira Women's Health Inc. 0.082
BDSX Biodesix, Inc. 0.3716
BIAF bioAffinity Technologies, Inc. 0.206
BIAFW bioAffinity Technologies, Inc. 0.17
BIOC Biocept, Inc. 0.4349
BNGO Bionano Genomics, Inc. 3.8355
BNR Burning Rock Biotech Limited 2.325
CDNA CareDx, Inc 15.36
CEMI Chembio Diagnostics, Inc. 0.455
CHEK Check-Cap Ltd. 0.8193
CNTG Centogene N.V. 0.325
CO Global Cord Blood Corporation 2.9876
CRL Charles River Laboratories International, Inc. 138.79
CSTL Castle Biosciences, Inc. 16.785
DGX Quest Diagnostics Incorporated 176.96
ETFs With Exposure to LMDX
Ticker ETF Name Weight Percentage Price
SPAK Defiance Next Gen SPAC Derived ETF 0.04 14.63
Unlock